BioGredient II ApS: Financial statements 2022
CVR: 37759724
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
BioGredient II ApS (CVR 37759724) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -14,447 compared with DKK 0 the year before. Equity in the 2022 report amounted to DKK -14,447.
- Profit/Loss
- DKK -14,447
- Equity
- DKK -14,447
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -14 t. | -14 t. | - |
| 2021 | - | - | 0 | 0 | - |
| 2020 | - | - | 0 | 0 | - |
| 2019 | - | 0 | 0 | 0 | - |
| 2018 | - | - | -40 t. | 0 | - |
Official annual report
Keep an eye on BioGredient II ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BioGredient II ApS
BioGredient II ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Nordic-Umami ApS. The company is owned by DACWR ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -14,447.